본문 바로가기
주메뉴 바로가기
HLBELL
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
Sitemap
Contact
ENG
KOR
ENG
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
SITEMAP
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
PR
Biotech Company Specialized in Regenerative Medicine
News
Notice
News
News
명지의료재단-에이치엘비그룹, 의료사업 등 협력
Date 2021.03.03
Hit 5179
기사원문 :
http://www.docdocdoc.co.kr/news/articleView.html?idxno=2008107
PREV
HLB그룹, 신약·백신유통사 900억원에 인수
NEXT
라이프리버, 바이오인공간 임상2b상 식약처 승인
LIST